|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-1-17
|
|
pubmed:abstractText |
Case-control and observational studies are popular choices for evaluating molecular prognostic/pharmacogenetic outcomes, but data quality is rarely tested. Using clinical trial and epidemiologic methods, we assessed the quality of prognostic and outcomes data obtainable from a large case-control study of lung cancer.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1055-9965
|
|
pubmed:author |
pubmed-author:BradburyPenelope APA,
pubmed-author:ChristianiDavid CDC,
pubmed-author:FidiasPanosP,
pubmed-author:HeistRebecca SukRS,
pubmed-author:KulkeMatthew HMH,
pubmed-author:LiuGeoffreyG,
pubmed-author:LynchThomas JTJ,
pubmed-author:MarshallAriela LAL,
pubmed-author:MillerDavid PDP,
pubmed-author:ParkSoheeS,
pubmed-author:SUKhKh,
pubmed-author:SequistLeciaL,
pubmed-author:ShepherdFrances AFA,
pubmed-author:TemelJenniferJ,
pubmed-author:WainJohn CJC,
pubmed-author:ZhouWeiW
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
204-11
|
|
pubmed:meshHeading |
pubmed-meshheading:18199725-Algorithms,
pubmed-meshheading:18199725-Case-Control Studies,
pubmed-meshheading:18199725-Clinical Trials, Phase II as Topic,
pubmed-meshheading:18199725-Clinical Trials, Phase III as Topic,
pubmed-meshheading:18199725-Feasibility Studies,
pubmed-meshheading:18199725-Female,
pubmed-meshheading:18199725-Humans,
pubmed-meshheading:18199725-Lung Neoplasms,
pubmed-meshheading:18199725-Male,
pubmed-meshheading:18199725-Outcome Assessment (Health Care),
pubmed-meshheading:18199725-Pharmacogenetics,
pubmed-meshheading:18199725-Pilot Projects,
pubmed-meshheading:18199725-Prognosis,
pubmed-meshheading:18199725-Questionnaires,
pubmed-meshheading:18199725-Survival Rate
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies.
|
|
pubmed:affiliation |
Princess Margaret Hospital/Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
